Literature DB >> 12445009

Comparison of screening methods for TEM- and SHV-derived extended-spectrum beta-lactamase detection.

F M MacKenzie1, C A Miller, I M Gould.   

Abstract

OBJECTIVE: To compare common extended-spectrum beta-lactamase (ESBL) screening methods and beta-lactams for their ability to detect TEM- and SHV-related ESBL enzymes.
METHODS: This study compared disk diffusion testing by NCCLS methodology, the Jarlier double disk test, a disk-on-disk test, a modified three-dimensional test and the E test method for their sensitivity and specificity in detecting TEM- and SHV-related ESBL producers. Three negative and 22 positive controls were studied. These were two Klebsiella pneumoniae and 23 Escherichia coli transconjugants. Seventeen beta-lactam antibiotics were tested: cefamandole, cefotetan, cefoxitin, cefuroxime, cefixime, cefoperazone, cefotaxime, cefpodoxime, cefsulodin, ceftazidime, ceftibuten, ceftizoxime, ceftriaxone, moxalactam, cefepime, cefpirome and aztreonam.
RESULTS: NCCLS disk diffusion was 14% sensitive with ceftriaxone, 36% with cefotaxime, 64% with aztreonam, 68% with cefpodoxime, and 73% with ceftazidime. Cefoperazone, cefamandole, cefpodoxime and cefpirome showed 91% sensitivity using the Jarlier test. Using the disk-on-disk test, cefsulodin showed 95% sensitivity, and cefoperazone, cefepime and cefamandole showed 91% sensitivity. With the modified three-dimensional test, cefoperazone, cefpodoxime and cefpirome showed 91% sensitivity.
CONCLUSIONS: For practical reasons, we would recommend use of either the Jarlier test or the commercial cephalosporin disks containing clavulanic acid to screen for ESBL producers. Cefoperazone, cefamandole, cefpodoxime and cefpirome showed good sensitivity across the methods tested.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12445009     DOI: 10.1046/j.1469-0691.2002.00473.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  8 in total

1.  Screening for extended-spectrum beta-lactamase-producing pathogenic enterobacteria in district general hospitals.

Authors:  Nteimam Jonathan
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

2.  Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for rapid detection of β-lactam resistance in Enterobacteriaceae derived from blood cultures.

Authors:  Jette Sophia Jung; Christina Popp; Katrin Sparbier; Christoph Lange; Markus Kostrzewa; Soeren Schubert
Journal:  J Clin Microbiol       Date:  2014-01-08       Impact factor: 5.948

3.  Modified Double Disc Synergy Test to Detect ESBL Production in Urinary Isolates of Escherichia coli and Klebsiella pneumoniae.

Authors:  Jaspal Kaur; Shashi Chopra; Gomty Mahajan
Journal:  J Clin Diagn Res       Date:  2013-02-01

Review 4.  Extended-spectrum beta-lactamases: a clinical update.

Authors:  David L Paterson; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

5.  Extended-spectrum beta-lactamase-producing bacteria in a tertiary care hospital in Madrid: epidemiology, risk factors and antimicrobial susceptibility patterns.

Authors:  Ines Rubio-Perez; Elena Martin-Perez; Diego Domingo Garcia; Manuel Lopez-Brea Calvo; Eduardo Larrañaga Barrera
Journal:  Emerg Health Threats J       Date:  2012-07-18

6.  Extended-spectrum β-lactamases in Gram Negative Bacteria.

Authors:  Deepti Rawat; Deepthi Nair
Journal:  J Glob Infect Dis       Date:  2010-09

7.  Prevalence of Extended Spectrum β-lactamase-Producing Klebsiella pneumoniae in Clinical Isolates.

Authors:  Khalid Abdalla Ali Abdel Rahim; Ahmed Mohamed Ali Mohamed
Journal:  Jundishapur J Microbiol       Date:  2014-11-01       Impact factor: 0.747

8.  Comprehensive Evaluation of the MBT STAR-BL Module for Simultaneous Bacterial Identification and β-Lactamase-Mediated Resistance Detection in Gram-Negative Rods from Cultured Isolates and Positive Blood Cultures.

Authors:  Annie W T Lee; Johnson K S Lam; Ricky K W Lam; Wan H Ng; Ella N L Lee; Vicky T Y Lee; Po P Sze; Rahim Rajwani; Kitty S C Fung; Wing K To; Rodney A Lee; Dominic N C Tsang; Gilman K H Siu
Journal:  Front Microbiol       Date:  2018-02-23       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.